Test to confirm the effect of a single intake of the test food on the suppression of postprandial blood glucose elevatio
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000053454
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Not provided
1)Those suffering from or undergoing treatment for serious renal or hepatic disease, cardiac, respiratory, endocrine, or other metabolic diseases. 2)Persons with chronic diseases and regular users of medicines. 3)Persons with gastrointestinal diseases affecting digestion and absorption and a history of gastrointestinal surgery (excluding appendicitis) 4)Persons taking medicines that may affect blood glucose levels. 5)Those who cannot stop taking supplements or health foods (including foods for specified health uses and foods with functional claims) that may affect blood glucose levels, blood lipids, or body fat during the study period. 6)Persons with a history or current medical history of drug or alcohol dependence. 7)Those who are unable to abstain from alcohol for 2 days prior to each examination. 8)Persons who are judged by the principal investigator to be unsuitable as research subjects based on blood tests performed during the screening test. 9)Those who are diagnosed as anemic by screening tests and are not suitable for frequent blood sampling. 10)Persons who developed diarrhea within 1 week prior to the screening test date, or who are normally prone to diarrhea. 11)Persons who have donated more than 200 mL of blood or component blood within 1 month or 400 mL within 3 months prior to the date of obtaining consent. 12)Those who have declared that they are allergic to the components of the research food (fruits) or to the load food (sesame). 13)Persons who are participating, or intend to participate, in studies (trials) involving the ingestion of other foods or the use of medicines, or the application of cosmetics and medicines. 14)Pregnant, intending to become pregnant during the study period, possibly pregnant, or breastfeeding. 15)Other persons deemed inappropriate as research subjects by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Area under the blood concentration curve (AUC) and change over time, Cmax, deltaCmax for glucose
- Secondary Outcome Measures
Name Time Method Area under the blood concentration curve (AUC) and change over time, Cmax, deltaCmax of insulin